Literature DB >> 18474709

The "Towards a Revolution in COPD Health" study: Comparing treatment strategies.

Anthony D D'Urzo1.   

Abstract

Year:  2008        PMID： 18474709      PMCID： PMC2377215     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  7 in total

1.  Canadian Thoracic Society COPD Guidelines: summary of highlights for family doctors.

Authors:  Denis E O'Donnell; Paul Hernandez; Shawn Aaron; Jean Bourbeau; Darcy Marciniuk; Rick Hodder; Meyer Balter; Gordon Ford; Andre Gervais; Roger Goldstein; Francois Maltais; Jeremy Road; Valoree McKay; Jennifer Schenkel
Journal:  Can Respir J       Date:  2003 May-Jun       Impact factor: 2.409

2.  The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial.

Authors:  Nicholas R Anthonisen; Melissa A Skeans; Robert A Wise; Jure Manfreda; Richard E Kanner; John E Connett
Journal:  Ann Intern Med       Date:  2005-02-15       Impact factor: 25.391

3.  Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice.

Authors:  J B Soriano; J Vestbo; N B Pride; V Kiri; C Maden; W C Maier
Journal:  Eur Respir J       Date:  2002-10       Impact factor: 16.671

4.  Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease.

Authors:  Peter Kardos; Marion Wencker; Thomas Glaab; Claus Vogelmeier
Journal:  Am J Respir Crit Care Med       Date:  2006-10-19       Impact factor: 21.405

5.  Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease.

Authors:  D D Sin; L Wu; J A Anderson; N R Anthonisen; A S Buist; P S Burge; P M Calverley; J E Connett; B Lindmark; R A Pauwels; D S Postma; J B Soriano; W Szafranski; J Vestbo
Journal:  Thorax       Date:  2005-10-14       Impact factor: 9.139

6.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema.

Authors:  Alfred Fishman; Fernando Martinez; Keith Naunheim; Steven Piantadosi; Robert Wise; Andrew Ries; Gail Weinmann; Douglas E Wood
Journal:  N Engl J Med       Date:  2003-05-20       Impact factor: 91.245

7.  Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group.

Authors: 
Journal:  Ann Intern Med       Date:  1980-09       Impact factor: 25.391
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.